Larkin, Karilyn T. M.
Byrd, John C.
Article History
First Online: 19 May 2021
Competing interests
: J.C.B. has received research support from Acerta Pharma, Genentech, Janssen Pharmaceutica, and Pharmacyclics and has served on the advisory boards of AstraZeneca, Novartis, Syndax Pharma and Trillium, and has substantial ownership interests in Vincerx Pharma. K.T.M.L declares no competing interests.